TELA Bio Inc. (TELA): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
TELA Bio, Inc. (TELA) maintains stable liquidity, with regular revenues from bio-implant sales fully covering operating expenses. Biomimetic-based OviTex innovative solutions are transforming hernia treatment methods, becoming a benchmark in surgery. The stock price retrospective on GURU.Markets, where the EV/EBITDA ratio is 0.00, accounts for risks associated with GPO dependency and a potential reduction in government procurement due to product costs.
פילוחי מדדים מקיפים ואנליטיקה עבור telabio.com (TELA)
The multiple compares the total enterprise value of TELA Bio, Inc. (TELA) including debt obligations, against its EBITDA, determining the asset payback period and the fundamental value of the business. The EV/EBITDA multiple trend reflects the scaling efficiency of OviTex matrix sales and margin growth, allowing investors to assess the fairness of the market share price relative to the company's actual operational efficiency.
